TipRanks
Chemomab Therapeutics (DE:2QV)
FRANKFURT:2QV
Germany Market
2QV
Chemomab Therapeutics
RESEARCH TOOLSreports

Chemomab Therapeutics (2QV) Stock News & Sentiment

1 Followers
Chemomab Refines Share Structure in Domestication Deal Ahead of Scipher Merger
Premium
Company Announcements
Chemomab Refines Share Structure in Domestication Deal Ahead of Scipher Merger
5d ago
6K
CMMB
Chemomab Therapeutics Files Q2 2026 Results and Updates SEC Registrations
Premium
Company Announcements
Chemomab Therapeutics Files Q2 2026 Results and Updates SEC Registrations
2M ago
6K
CMMB
Chemomab Therapeutics and Scipher Medicine to Merge in AI‑Driven Rheumatoid Arthritis Play
Premium
Company Announcements
Chemomab Therapeutics and Scipher Medicine to Merge in AI‑Driven Rheumatoid Arthritis Play
3M ago
6K
CMMB
Chemomab Therapeutics Revamps Board and Committees With New Independent Director
Premium
Company Announcements
Chemomab Therapeutics Revamps Board and Committees With New Independent Director
4M ago
6K
CMMB
Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
Premium
Ratings
Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
5M ago
CMMB
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
Premium
Company Announcements
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
5M ago
6K
CMMB
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
Premium
Company Announcements
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
5M ago
6K
CMMB
More DE:2QV News >

2QV News on the Web

Chemomab Therapeutics Files Q2 2026 Results and Updates SEC Registrations
TipRanks News
Neutral
Chemomab Therapeutics (CMMB) Enters Merger with Scipher Medicine
GuruFocus News
Neutral
Chemomab Therapeutics, Scipher Medicine announce merger agreement
TipRanks News
Bullish
Chemomab Therapeutics and Scipher Medicine to Merge in AI‑Driven Rheumatoid Arthritis Play
TipRanks News
Neutral
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
rttnews
Bullish
Chemomab Therapeutics Revamps Board and Committees With New Independent Director
TipRanks News
Neutral
Top Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On Watch
rttnews
Neutral
Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:2QV
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2QV’s Media Buzz Sentiment?
Currently, no data Available
What is DE:2QV’s weekly average amount of articles?
Currently, no data Available
What is DE:2QV’s News Sentiment?
50% of articles about DE:2QV were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    XERSXeris Pharmaceuticals
    QTTBQ32 Bio
    ABTAbbott Laboratories
    GMABGenmab
    BAYRYBayer
    Showing the stocks with the most bullish news sentiment over the past week